Dr Céline Schiff-Deb
Dr. Céline Schiff-Deb joined Calysta, a leading company in the development and manufacture of new alternative proteins in January 2018, as Senior Director Product Innovation.
For over fifteen years, Dr. Schiff-Deb has been working at the interface of science and business, turning biotechnological innovations into relevant commercial products and services, both in Europe and in the USA.
Native from France, she completed a Master’s degree in agronomy delivered by Agro Paris Tech and went on to receive her Ph.D in plant genetics and molecular biology at Agro Paris Tech and Stanford University.
Having acquired a strong sense of the potential of biological systems to produce compounds of interest, she decided to leverage her scientific background to help companies translate these innovations into commercial products. For seven years, she worked in consulting and strategy in the biotechnology space, both with a specialized consulting firm – Alcimed – and as an independent consultant.
Since 2011, she has been leveraging her expertise by joining biotechnology companies built around microbial platforms: Intrexon, Solazyme/TerraVia/Corbion and now Calysta. She has a solid track record of securing strategic partners, developing new products and successfully launching them in the market place in the areas of nutrition, cosmetic, chemicals, oil and gas.
Since joining Calysta, she is leading the development of new sustainable products and applications to improve worldwide food security, leveraging Calysta’s proprietary fermentation platform.
Celine will be speaking on Panel 4: The New Protein Pioneers